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Abstract
Background: Identifying the influence formalin fixation has on RNA integrity and recovery from
clinical tissue specimens is integral to determining the utility of using archival tissue blocks in future
molecular studies. For clinical material, the current gold standard is unfixed tissue that has been
snap frozen. Fixed and frozen tissue however, both require laser capture microdissection to select
for a specific cell population to study. The recent development of a sampling method capable of
obtaining a viable, enriched cell population represents an alternative option in procuring cells from
clinical material for molecular research purposes. The expression profiles of cells obtained by using
this procurement approach, in conjunction with the profiles from cells laser capture microdissected
from frozen tissue sections, were compared to the expression profiles from formalin fixed cells to
determine the influence fixation has on expression profiles in clinical material.
Methods: Triplicate samples of non-neoplastic colonic epithelial cells were recovered from a
hemicolectomy specimen using three different procurement methods from the same originating
site: 1) an exfoliation and enrichment strategy 2) laser capture microdissection from formalin fixed
tissue and 3) laser capture microdissection from frozen tissue. Parameters currently in use to
assess RNA integrity were utilized to assess the quality of recovered RNA. Additionally, an
expression microarray was performed on each sample to assess the influence each procurement
technique had on RNA recovery and degradation.
Results: The exfoliation/enrichment strategy was quantitatively and qualitatively superior to tissue
that was formalin fixed. Fixation negatively influenced the expression profile of the formalin fixed
group compared to both the frozen and exfoliated/enrichment groups.
Conclusion: The exfoliation/enrichment technique represents a superior alternative in tissue
procurement and RNA recovery relative to formalin fixed tissue. None of the deleterious effects
associated with formalin fixation are encountered in the exfoliated/enriched samples because of the
absence of its use in this protocol. The exfoliation/enrichment technique also represents an
economical alternative that will yield comparable results to cells enriched by laser capture
microdissection from frozen tissue sections.
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Background
Advances in biotechnology have made possible the eluci-
dation of the transcriptome, defined as the complete set of
RNA transcripts produced by the genome at any one time.
Although most studies to date have been based on cell cul-
tures or animal models, the value of this technology
would be its application to human clinical tissue speci-
mens [1]. Two major impediments have prevented the
widespread use of expression profiling on human tissue:
tissue complexity and RNA recovery and degradation. Tis-
sue complexity refers to the presence of multiple cell types
that constitute and contribute to the overall makeup of tis-
sue. This issue is not addressed in most studies that use
clinically derived tissue, although the difficulties in inter-
preting molecular findings from heterogeneous tissue sec-
tions has been well documented [2]. Incomplete RNA
recovery and degradation are factors that can negatively
impact expression profiling studies [3-5]. The most preva-
lent form of clinical material available for study is in the
form of formalin fixed, paraffin embedded (FFPE) tissue.
Issues of cell heterogeneity can now be circumvented due
to the development of laser capture microdissection
(LCM) [6]. However, issues relevant to obtaining a repre-
sentative in vivo transcriptome are still present if FFPE
material is the tissue source. Delays in fixation, autolysis
and cross linking may alter the recovery of RNA or con-
tribute to its degradation [7]. Therefore, studies based on
FFPE tissue cannot claim to report a truly representative
baseline transcriptome. Instead, most studies attempt to
document the effect of FFPE on RNA integrity and tran-
script expression by comparing RNA related parameters
between tissue fixed in different types of fixatives or tissue
that has been frozen. Although frozen tissue has long
been the gold standard for preservation of RNA in clinical
tissue sections, to date there has been no other procure-
ment method for comparison.
A recently developed procurement protocol capable of
recovering a specific, enriched cell population from solid
clinical tissue was utilized in this study to obtain fresh,
unfixed cells from a resected tissue specimen [8]. The pro-
curement protocol is capable of recovering viable cells
within minutes after extirpation of a tissue specimen. The
procurement technique therefore represents a close
approximation of cells to their in vivo state, and thus can
theoretically serve as the control material from which to
help define a baseline transcriptome. Using this procure-
ment technique in conjunction with analysis of frozen
LCM cells, the influence of FFPE on the recovery, integrity
and degradation of RNA in tissue sections can be ascer-
tained.
The procurement technique, which comprises the action
of exfoliation and takes advantage of selective enrich-
ment, does not destroy the integrity of the underlying tis-
sue. It therefore represents an ideal method to examine
the relationship between RNA and FFPE because the area
from where cells were exfoliated from can later be frozen
or fixed. Using a freshly resected hemicolectomy speci-
men, colonic epithelial cells were obtained by one of three
methods 1) exfoliation + enrichment 2) FFPE + LCM and
3) freezing of tissue + LCM. Because only one cell type
from the same area was studied but collected by 3 differ-
ent methods, we were able to examine the influence FFPE
has on RNA recovery and integrity.
Methods
Tissue and cell procurement from fresh tissue
Approval for the following studies were obtained from the
Institutional Review Board at the State University of New
York at Buffalo. A hemicolectomy specimen excised for
curative purposes was obtained in the operating suite at
the time of extirpation. The specimen was transported
unopened on ice to the Department of Pathology within
3 minutes where it was opened and briefly rinsed in 0.9%
normal saline [9]. At a distance 5 cm from the grossly
obvious tumor mass, non-neoplastic colonic epithelial
cells were manually exfoliated. Manual exfoliation of the
cells was accomplished by applying the edge of a glass
slide to the exposed surface of the opened colonic resec-
tion specimen and gently scraping it. It is a modification
of a technique initially describe by Yang who utilized it as
an intraoperative diagnostic tool [10]. We quickly realized
that this technique could partially purify a population of
cells unencumbered by the deleterious effects of fixative.
Adding laser capture microdissection to the technique
enabled the recovery of highly intact nucleic acids and
proteins from a select cell population [11]. We further
modified our approach to expedite the entire procure-
ment process by introducing magnetic beads bound with
the antibody ber-Ep4 (Dynal Epithelial Enrich, Invitro-
gen) to the exfoliated cell population. This reduced the
overall time frame of the procurement process and the
need to purchase a laser capture microdissection machine
while achieving comparable results for nucleic acid integ-
rity and protein recovery [8]. The use of magnet beads
embedded with the ber-Ep4 antibody was a logical choice
because colonic epithelial cells strongly and diffusely
express the epitope recognized by this antibody (Figure 1)
[12,13]. The fact that no other cells in colonic tissue
express ber-Ep4 allows us to selectively enrich for colonic
epithelial cells (Figure 2). The enrichment step was neces-
sary because exfoliation by itself resulted in the recovery
of other cells types in the lamina propria, most notably
lymphocytes and plasma cells. Enough cells were exfoli-
ated so as to recover triplicate samples. An additional sam-
ple was collected to assess cell viability (Figure 3).
The enrichment step involved introducing the ber-Ep4
antibody bound magnetic beads to the exfoliated cellsBMC Clinical Pathology 2007, 7:7 http://www.biomedcentral.com/1472-6890/7/7
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and allowing them to mix at 4°C for 20 minutes in PBS +
0.1% bovine serum albumin buffer. The unbound cells
were then discarded after a magnet was used to immobi-
lize and retain the bound cells. This wash step was per-
formed twice.
While the colonic epithelial cells underwent the 20
minute mix with the ber-Ep4 bound magnetic beads, the
colonic resection specimen was revisited. The exact sec-
tion from where the cells were exfoliated was sectioned to
produce two 2 cm mirror faces. We had previously found
that the process of exfoliation was gentle enough that it
did not destroy the tissue architecture from where the cells
were procured. This added benefit therefore allowed his-
tologic correlation of tissue with any downstream studies
performed on the exfoliated cells. It is also the reasoning
that formed the basis of this study. The two cut mirror
faces of tissue were then excised, with one piece placed in
10% Neutral Buffered Formalin (NBF) and the other piece
frozen on Optimal Cutting Media (Sakura Finatek) (Fig-
ure 4). The tissue placed in NBF was done while the exfo-
liated cells were undergoing the enrichment step. The
tissue section was allowed to fix for 8 more hours to sim-
ulate typical fixation conditions for tissue anatomical sur-
gical pathology specimens. Following fixation, the tissue
was processing further on a Miles Scientific Tissue-Tek VIP
automated processor. The program entailed an additional
2.5 hours in 10% NBF, followed by dehydration and then
three separate cycles of infiltration by paraffin wax lasting
30, 60 and 60 minutes. In order to simulate archival con-
ditions, it was maintained in storage at room temperature
for one month.
Viability of recovered cells by the exfoliation/enrichment  strategy Figure 3
Viability of recovered cells by the exfoliation/enrich-
ment strategy. The absence of blue staining in the colonic 
epithelial cells recovered after using exfoliation/enrichment 
indicates the cells recovered by this approach are viable. The 
yellow dots are the immunomagnetic beads (40×).
Expression of ber-Ep4 in colon cells Figure 1
Expression of ber-Ep4 in colon cells. Immunohistochem-
istry of section of non-neoplastic colon tissue demonstrating 
expression by all colonic epithelial cells to the ber-Ep4 anti-
body. Note absence of expression in cells in the lamina pro-
pria. The difference in expression is exploited in the 
enrichment strategy for colonic epithelial cells from fresh tis-
sue. (10×).
Recovery of an enriched colon cell population using the exfo- liation/enrichment strategy Figure 2
Recovery of an enriched colon cell population using 
the exfoliation/enrichment strategy. Colonic epithelial 
cells devoid of inflammatory cells and other cell types recov-
ered using the exfoliation and enrichment strategy on fresh 
tissue. The yellow dots are the immunomagentic beads (H&E, 
20×).BMC Clinical Pathology 2007, 7:7 http://www.biomedcentral.com/1472-6890/7/7
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The frozen section of tissue was retained in the cryostat
while the exfoliated cells underwent the enrichment step.
Afterwards, the tissue section was transferred to a -80°C
freezer for storage.
After the two wash steps, 50 μL of a commercially availa-
ble phenol+guanidine isothiocyanate solution (Trizol,
Invitrogen) was added to each of the three enriched cell
samples. The cells were then disrupted using a disposable
minipestle (Argos Technologies). An additional 950 μL of
Trizol was added to the cell lysates and cell disruption
continued by repetitive pipetting. The cell lysates were
then frozen and retained in a -80°C freezer. To simplify
the discussion, this group will hereafter be designated as
Group 1.
Cells procured for assessment of cell viability
The sample procured for cell viability assessment was
processed alongside those collected by exfoliation and
enrichment. Instead of freezing and lysing the cell pellet,
they were retained in PBS. Five microliters of the resus-
pended cell mixture was then diluted with Trypan Blue
dye exclusion media to achieve a 1:20 ratio. The mixture
was then transferred to a hemocytometer chamber and
left undisturbed for 1 minute. The cells were then exam-
ined (Figure 3).
Cell procurement from FFPE and frozen tissue blocks
After a month in storage, five micrometer thick sections
were cut from the FFPE tissue block and placed on
uncharged, RNase free slides (HistoGene™ LCM Frozen
Section Staining Kit, Arcturus). The tissue section was then
allowed to air dry at room temperature in a desiccant jar
followed by dehydration, staining and rehydration using
HistoGene™ RNase free solutions. The slides were then
transferred to a desiccant jar and allowed to air dry at
room temperature. In triplicate, colonic epithelial cells
were laser capture microdissected using a PixCell II LCM
machine (Arcturus) using a spot size of 15 μm, 70 mW of
power and 295 volts. Approximately 2,000 pulses were
used to procure colonic epithelial cells. This was done in
triplicate. The polymer LCM cap for each sample was then
fitted into a sterile microcentrifuge tube and kept on ice.
Using sterile techniques, the polymer caps containing the
microdissected cells were separated from the underlying
caps using a scalpel blade and deposited into 3 separate
microcentrifuge tubes containing 50 μL Trizol. The
attached cells were disrupted as previously described
before additional Trizol was added followed by freezing
and retention in a -80°C freezer. The triplicate samples of
cells procured by LCM from FFPE tissue sections will here-
after be referred to as Group 2.
After one month of storage, the frozen tissue block was
retrieved from the -80°C freezer and allowed to equili-
brate in a cryostat. The tissue block was then sectioned
into 5 micrometer thick sections and placed on uncharged
RNase free slides. In triplicate, colonic epithelial cells were
procured by LCM in the exact same manner as previously
described for the FFPE tissue block. The triplicate samples
of cells procured by LCM from frozen tissue section will
hereafter be referred to as Group 3.
Study design Figure 4
Study design. From a freshly resected colectomy specimen, 
three types of procurement were performed from tissue 
originating from the same site. In the fresh state, cells in 
Group 1 are exfoliated and enriched for using ber-Ep4(+) 
magnetic beads. The area from where these cells came from 
was then sectioned into 2 mirror pieces, with one fixed in 
formalin and the other frozen. For the latter two, colon cells 
were obtained by laser capture microdissection. After exfo-
liation, RNA was extracted in parallel from all the samples 
and afterwards underwent expression profiling on an 
Affymetrix microarray chip. The results were compared 
between the samples within each group and against the sam-
ples in other groups. EE = exfoliation/enrichment, FFPE = 
formalin fixed, paraffin embedded, LCM = laser capture 
microdissection, EP = expression profile assay.
EE
Colon resection
specimen
EE EE
LCM LCM LCM LCM LCM LCM
FFPE
Freeze
tissue
EP EP EP EP EP EP EP EP EP
Group 1 Group 2 Group 3
Evaluation of RNA recovery,
integrity and comparative analysis
of expression profilesBMC Clinical Pathology 2007, 7:7 http://www.biomedcentral.com/1472-6890/7/7
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Extraction, purification and qualitative analysis of 
recovered RNA
In parallel, total RNA from Groups 1, 2 and 3 were
extracted following the manufacturer's recommendations
(Trizol, Invitrogen). Recovered RNA was purified using
Qiagen spin columns. For RNA, values greater than 1.8, as
measured by the absorbance ratio between 260 and 280
nm, were considered acceptable criteria of purity. The
eluted RNA was then quantitated and analyzed through
capillary electrophoresis for integrity using the RNA 6000
PicoLabChip kit on the Agilent 2100 BioAnalyzer follow-
ing the manufacturer's recommendations. In addition, the
raw data was analyzed using Degradometer software [14].
In this software program, RNA is categorized into one of
four color annotated groups based on increasing amounts
of degradation.
Expression Microarray
Equimolar quantities of total RNA from each of the 3
groups were prepared for amplification as previously
described [15]. Total RNA was isolated and cleansed using
RNAeasy columns. Total RNA double stranded cDNA was
synthesized using the Superscript Choice System. A T-7
(d24) primer was used to prime the first strand cDNA syn-
thesis. An in vitro transcription reaction (IVT) was then
followed by a second round of amplification. The final
IVT reaction was performed in order to further amplify
and biotinylate the samples. At each stage of this process
the quality of the samples was monitored using both gel
electrophoresis and spectrophotometry. The full length
cRNAs were then fragmented to 20–200 base pairs. The
quality of the array hybridization was evaluated by deter-
mining if the 5' ratio was at least half of the 3' ratio indi-
cating that the starting poly-A RNA was of a quality to
yield full-length cDNAs. We also compared the intensities
of samples to each other and compared these to genes
which have been spiked into the samples at known con-
centrations. The Affymetrix Human U133 Plus 2.0 chips
used in these experiments were arrayed with sequence
specific oligonucleotides representing 54,000 genes. The
sequences from which the probe sets were derived were
selected from GenBank®, db-EST, and RefSeq. The
sequence clusters were created from the UniGene data-
base (Build 133, April 20, 2001) and then refined by anal-
ysis and comparison with a number of other publicly
available databases, including the Washington University
EST trace repository and the University of California,
Santa Cruz Golden-Path human genome database (April
2001 release). In addition, there were 9,921 new probe
sets representing approximately 6,500 new genes. These
gene sequences were selected from GenBank, dbEST, and
RefSeq. Sequence clusters were created from the UniGene
database (Build 159, January 25, 2003) and refined by
analysis and comparison with a number of other publicly
available databases, including University EST trace repos-
itory and the NCBI human genome assembly (Build 31).
The array represents the most comprehensive coverage of
the genome that is currently available. Labelled cRNA was
then fragmented and hybridized unto Affymetrix HGU
133 Plus 2.0 chips.
Analysis of microarray results
The significant differences in gene expression levels for
each comparison set were derived using GC Rapid Micro-
array Analysis (GCRMA) software (Affymetrix). Data was
normalized with a significance cut off of p = 0.05 and the
false discovery rate of less than 0.05. GCRMA analyzes
each hybridized chip in the context of other chips in the
experiment. The algorithm consists of three steps – a
sophisticated computation that uses each probe's
sequence information to adjust the measured intensity for
the effects of non-specific binding of G and C nucleotides
in each probe, a quantile normalization stage that aligns
expression values to a common distribution, and finally,
an iterative median polishing procedure that summarizes
the data and generates a single expression value for each
probe set.
Transcript levels for the constitutively expressed house-
keeping genes β-actin and GAPDH were measured as a
means of assessing degradation. Measurement of the
probe sets to the 3' and 5' regions to these genes can yield
informative data on degradation. A three fold or greater
difference in the 3'/5' ratio is one indication of degrada-
tion in an expression array data set. A numerical value of
4 or under is considered acceptable. For the remainder of
genes in the transcriptome, a difference in the log 2 ratio
of a gene probe set between the three groups was consid-
ered indicative of either an alteration in transcript levels or
transcript loss. The loss was attributed to either degrada-
tion or poor recovery.
In order to assess the reproducibility of the procurement
techniques, each sample within each group was compared
to the other samples in their respective groups using Gen-
etraffic software (Stratagene). Each scatter plot was then
exported to excel to allow for the generation of Pearson
correlation ratios. A linear correlation with ratios greater
than 0.7 would indicate a strong positive correlation
between samples collected by one procurement method.
Alterations in the ratio would indicate changes occurring
in the transcript levels between samples within each
group. Since the samples were being compared to each
other and only with those within their group, the changes
in transcript levels would be attributable to either poor
recovery or degradation.BMC Clinical Pathology 2007, 7:7 http://www.biomedcentral.com/1472-6890/7/7
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Assessing the impact of procurement method on individual 
gene expression profiles
Representative genes were selected from the expression
profiles from each group and compared to each other.
Since the study was designed so that only one cell type
would be procured, the only variable different between
each group would be the procurement method (Group 1
= exfoliation/enrichment; Group 2 = FFPE + LCM; Group
3 = frozen tissue + LCM). Ideally, the expression of specific
genes should be similar in all three groups. Alterations in
RNA integrity Figure 5
RNA integrity. Representative electropherograms of 18S and 28S ribosomal RNA peaks from each sample procurement 
group. 5A = Group 1, 5B = Group 2, 5C = Group 3. See text for details.
5A 
  
5B      
  
5C           
Table 1: RNA recovery for each sample group
Procurement method Total RNA (ng/μL) Degradometer (range) B-actin 3'/5' ratio GAPDH 3'/5' ratio
Group 1 1,546.80 Orange – red 24.1% (19.52 – 28.69) 5.6 3.8
Group 2 49.27 Black 58.6% (56.32 – 60.37) 18.4 15
Group 3 59.96 Black 41.2% (40.92 – 41.55) 9.9 19.3
Measurements of recovery and metrics of degradation for each sample procurement method for RNA in each group. Group 1 = exfoliation/
enrichment approach, Group 2 = FFPE + LCM method, Group 3 = Frozen tissue section + LCM. Classification of Degradometer parameters: 
Yellow = degradation between 8–16%, orange = degradation between 16–24%, red = degradation > 24% and black = extensive degradation from 
which non-reliable data may be generated.BMC Clinical Pathology 2007, 7:7 http://www.biomedcentral.com/1472-6890/7/7
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the transcript level would be attributable to the conditions
associated with the procurement method. A supervised
hierarchical cluster algorithm (dChip, Harvard, MA) was
utilized for this comparison.
Results
Viability or Recovered Cells by the Exfoliation/Enrichment 
method
Examination of the cells dedicated for examination of cell
viability by Trypan Blue staining showed that the vast
majority of recovered cells excluded the dye from their
cytoplasm. On average, 94% of the cells did not demon-
strate cytoplasmic staining (Figure 4).
RNA recovery and Degradometer results
Sufficient RNA was recovered from every sample extrac-
tion. The average amount of total RNA from Group 1 was
1,546.8 ng/μL (Table 1). For Group 2 the average amount
of total RNA was 49.27 ng/μL and for Group 3 it was
59.96 ng/μL. The average OD 260/280 absorbance ratio, a
measure of nucleic acid purity, was 1.99 for Group1, and
1.69 for Group 2 and 1.70 for Group 3. Nucleic acid integ-
rity assessed using the Agilent 2100 BioAnalyzer demon-
strated the presence of 18S and 28S peaks in Group 1 but
none in either Group 2 or 3 (Figure 5). The absence of 18S
and 28S peaks in the latter two groups may be reflective of
the enrichment process, as others have reported encoun-
tering absent ribosomal peaks but retention of intact
mRNA levels for specific genes [16]. Degradometer soft-
ware indicated the average degradation factor for Group 1
was 24.1%, for Group 2 it was 58.6% and for Group 3 it
was 41.2%.
Microarray results
Following 2 rounds of amplification, all samples con-
tained sufficient RNA for the microarray hybridization.
The 3'/5' ratio for β-actin for Group 1 was 5.6, 18.4 for
Group 2 and 9.9 for Group 3. The 3'/5' ratio for GAPDH
for Groups 1, 2 and 3 were 3.8, 15 and 19.3, respectively.
The comparison between the hybridization signals
between Group 1 and Group 2 demonstrated 13,544 gene
probe sets exhibiting a log 2 fold change or 2 or greater
between the two groups (Table 2). This represented 25%
of the total gene probe sets in the chip. In the comparison
between the hybridization signals between Groups 1 and
3 there were 699 gene probe sets demonstrating a log 2
fold change or greater between them. This represented
1.9% of the gene probe sets in the chip. In order to gain
further insight into these changes, we examined the Gene
Ontology Biologic Process ascribed to these altered gene
transcripts. The largest contingents belonged to genes
involved in transcription, signal transduction, protein
metabolism, cell adhesion and cytoskeletal organization.
In comparing the hybridization signals between Group 2
and Group 3, there were 10,344 gene probe sets showing
a log 2 fold change or greater between these two groups.
This represented a difference in 19% of the gene probe sets
in the chip.
Reproducibility in procurement method
Pearson correlation plots between like samples within
each group were 0.8198 for Group 1, 0.0268 for Group 2
and 0.4166 for Group 3 (Figure 6).
Comparative analysis of transcripts levels between 
matched genes collected by different procurement 
methods
The supervised cluster algorithm demonstrated that sev-
eral gene products were expressed in both Group 1 and
Group 3, but were lacking in Group 2 (Figure 7). Addi-
tionally, several transcripts were found to be expressed in
Group 2 but were not present in either Group 1 or Group
3.
Discussion
A major impediment in working with clinical material is
the inherent heterogeneity present in tissue specimens.
The set of gene transcripts responsible for defining the
homeostasis, function and phenotype for a cell are differ-
ent for each cell type. Obtaining an expression profile for
a portion of tissue is informative for that piece of tissue,
necessitating exhaustive work to determine those tran-
scripts specific to any cell present in the tissue. A recently
developed approach to procuring a homogeneous cell
population for molecular studies can be achieved through
the use of laser capture microdissection. However, issues
regarding the sample source introduce new variables
when molecular studies are being considered. The most
Table 2: Comparison of expression profiles between the three procurement groups
Comparison group Number of gene probe sets with ≥ 2 fold 
change
Percentage of gene probe sets with ≥ 2 
fold change
Group 1 vs. Group 2 13,544 25%
Group 1 vs. Group 3 699 1.9%
Group 2 vs. Group 3 10,344 19%
Comparison of results between sample procurement groups after amplification and hybridization onto Affymetrix HGU133 Plus 2.0 chips. 
Similarities in the expression profile were greatest between Groups 1 and 3, with significant differences apparent between Groups 1 and 2 and 
Groups 2 and 3.BMC Clinical Pathology 2007, 7:7 http://www.biomedcentral.com/1472-6890/7/7
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common and widely available tissue source is formalin
fixed and paraffin-embedded. It has been repeatedly dem-
onstrated that the process of fixation incurs alterations in
the RNA molecules present in cells [3-5]. Delays in fixa-
tion, exposure to hypoxic conditions, tissue nucleases and
fixative associated cross-linking are variables associated
with archived fixed tissue specimens that may lead to
either RNA degradation or reduced recovery [7,17].
Although there have been attempts to evaluate the effect
the process of FFPE has on the expression profile of cells
in clinical tissue specimens, none have compared FFPE
with unfixed, enriched control cells. Trypsinizing cultured
cells prior to fixation and comparing them to non-
trypsinized cultured cells does not recapitulate the condi-
tions surgical pathology specimens are exposed to [18].
Exposure to trypsin disaggregates and separates cell clus-
ters to individual cells. Individual cells thus have a greater
surface area for exposure to fixative. In contrast, cells in
tissue are dependent upon the relations of the distance
they are from an exposed cut surface and the speed with
which formalin progresses in tissue. Thus, because most
pathological tissue sections are cut at a thickness of 5 mm
and formalin travels in tissue at a rate of 1 mm/hour, the
transcriptome of matched cell types may demonstrate
regional differences in a fixed tissue section. Although real
time PCR can elucidate gene expression patterns, it is lim-
ited in the number of genes it can assess at one time. The
development of newer technologies capable of assaying
larger numbers of gene products holds great promise, but
experiments again should be designed to replicate clinical
conditions. The reproducibility or an expression profile
should reflect the reproducibility of the tissue sections
and not the technology [19]. In comparing the expression
profiles of one section of tissue, the newly developed
DASL technique demonstrated excellent reproducibility.
Unfortunately, several separate tissue sections at different
depths of the tissue block should have been examined to
assess the effects FFPE has on reproducibility.
In this paper we introduce a technical method for the pro-
curement of a viable, enriched cell population not adul-
terated by the effects of fixative. This exfoliation and
enrichment approach represents a superior alternative in
the procurement of specific cells relative to FFPE clinical
material. This statement is based on the β-actin, GAPDH,
Degradometer and ribosomal RNA (18/28S ratios)
results. The one factor that is generally out of the control
for procurement is pre-extirpation surgical anoxia [17].
This however, is equal in the tissue between the samples
collected by the 3 different methods. Additionally, based
on the amounts of RNA recovered, this procurement tech-
nique represents a more economical and expeditious
method for obtaining specific cell populations from clin-
ical material for molecular studies. A 5 ml vial of antibody
bound magnetic beads costs less than $1,000. We utilized
Reproducibility of expression arrays between replicates Figure 6
Reproducibility of expression arrays between repli-
cates. Scatterplots of samples within each group to assess 
reproducibility of the procurement method. 6A = Represent-
ative scatterplot between two of the samples in Group 1. 6B 
= Representative scatterplot between two samples in Group 
2. 6C = Representative scatterplot between two of the sam-
ples in Group 3.
6A                                                                    
  
6B 
6C
r = 0.8198 BMC Clinical Pathology 2007, 7:7 http://www.biomedcentral.com/1472-6890/7/7
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Comparison of expression profile for selected genes between the three different procurement methods Figure 7
Comparison of expression profile for selected genes between the three different procurement methods. 
Expression profile of selected genes between the 3 different methods show a greater degree of similarity between Groups 1 
and 3 than either with Group 2. Redundant genes indicate the presence of multiple probes, with the genes in the lower half of 
the cluster diagram indicating degeneration at one end of the mRNA species for that gene.BMC Clinical Pathology 2007, 7:7 http://www.biomedcentral.com/1472-6890/7/7
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only 40 μL for each sample in Group 1. Thus, the potential
to acquire 125 samples for under $1,000 exists.
The decision to examine an area of non-neoplastic colonic
tissue was chosen for several reasons. First, non-neoplastic
cells of the same lineage should demonstrate similar
expression profiles. The heterogeneity in neoplastic clones
in a tumor specimen may yield different expression pro-
files. Second, the method of enrichment in this technique
takes advantage of the uniform and diffusely strong
expression of the epitope for the ber-Ep4 antibody. This
antibody, coupled to magnetic beads, enables enrichment
of ber-Ep4 (+) cells once they are exfoliated from the tis-
sue. Third, the technique of exfoliation does not destroy
the underlying tissue architecture. The exact location that
the cells were exfoliated from can then be excised, fixed or
frozen, stained, visualized, and the exact same cell type
laser capture microdissected for comparative analysis.
Laser capture microdissection was necessary for the FFPE
and frozen tissue sections in order that the expression pro-
file from the same cell type could be compared to those
recovered by the exfoliation and enrichment method.
Finally, only one type of tissue was examined so the effects
of fixative on a specific cell's expression profile could be
determined. By doing each procurement method in tripli-
cate, we could determine the reproducibility of the collec-
tion method. Group 1 demonstrated the highest Pearson
correlation and most reproducible profiles, followed by
Group 3. Group 2 on the other-hand, demonstrated poor
reproducibility.
Since the constant between each sample group was the
same cell type, and since extraction of RNA and the
hybridization studies were done in parallel, the only vari-
able present was exposure to fixative. Group 3 represents
the current gold standard for expression analysis because
RNA molecules are suspended by freezing for subsequent
examination. Since Groups 1 and 3 were not exposed to
fixative and demonstrated highly reproducible replicates,
they served as a baseline from which to compare expres-
sion profiles. The expression profiles between Groups 1
and 3 demonstrated a 2 fold log 2 difference in only 1.5%
of their transcripts. The differences between Groups 1 and
3 although small, may be attributable to some degree in
the procurement approach of the cells in Group 1. The
manipulation of these cells, exposure to buffer and bind-
ing of these cells to antibodies conjugated to magnetic
beads can lead to changes in the transcript levels for cer-
tain genes. Examination of the Gene Ontology Biological
Process for these gene probe sets confirmed that the
majority of these changes could be attributable and the
result of the manipulation the cells in Group 1 experi-
enced. In contrast Group 2, the colonic cells that were
fixed in formalin, processed to paraffin embedding and
then LCM, exhibited a 25% difference in the log2 values
between the genes in this group and Group 1. Examina-
tion of individual gene transcript levels between the three
groups demonstrated more similarities between the two
unfixed groups than with the fixed group.
Finally, the use of the exfoliation and enrichment tech-
nique may prove integral in the elucidation of the molec-
ular events in adenocarcinoma of the colon. Currently,
there exists no cell line for non-neoplastic colon cells
[20,21]. In the scientific arena, alterations in transcript
levels are thought to contribute to the pathogenesis of
neoplasia. In the clinical arena, without an established
baseline transcriptome representative of in vivo, non-neo-
plastic colonic cells, determining which genetic altera-
tions are contributory to the pathogenesis of
adenocarcinoma of the colon would be difficult. Only
one type of tissue was studied so the effects of formalin
fixation on RNA integrity, recovery and subsequent per-
formance in an expression format could be examined.
Because every cell type in the human body is distinctive
both phenotypically and genotypically, a similar
approach may need to be performed in future studies of
specific cell types. In our practice, exfoliation of cells
works well for the recovery of intact cells from all normal
and tumor tissue types excepting bone and fat. The current
limiting factor in the technique is the enrichment
approach, specifically, the identification of antibodies
specific to preferentially expressed plasma membrane pro-
teins on different cell types. We envision that in the future,
when the plasma membrane proteome becomes pub-
lished, this technique can be expanded to include other
tumor types and experiments designed to collect only spe-
cific cell types.
Conclusion
The technique of exfoliation and enrichment enables
recovery of a viable population of non-neoplastic colonic
epithelial cells from clinical material. Cells recovered by
this method demonstrate superior molecular parameters
regarding reproducibility and integrity when compared to
similar cells exposed to formalin fixation. Taking into
consideration the small number of genes that have been
noted to have an altered gene expression level, this tech-
nique can also be utilized as an alternative to frozen tis-
sue.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
Each author contributed in the research performed to
complete this report. WDM designed the project, obtained
and performed the collection of cells by the three different
procurement methods and wrote the majority of the arti-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Clinical Pathology 2007, 7:7 http://www.biomedcentral.com/1472-6890/7/7
Page 11 of 11
(page number not for citation purposes)
cle. LS wrote portions of the methods and results, per-
formed the analysis of microarray data and development
of the figures. LH wrote portions of the methods, results,
discussion and contributed in the analysis of the data.
Acknowledgements
The authors wish to thank Jennifer Rothschild for providing technical assist-
ance with the microarray assays. This work was supported by a grant from 
the Kaleida Health Foundation.
References
1. Emmert-Buck MR, Strausberg RL, Krizman DB, Bonaldo MF, Bonner
RF, Bostwick DG, Brown MR, Buetow KH, Chuaqui RF, Cole KA,
Duray PH, Englert CR, Gillespie JW, Greenhut S, Grouse L, Hillier
LW, Katz KS, Klausner RD, Kuznetzov V, Lash AE, Lennon G, Linehan
WM, Liotta LA, Marra MA, Munson PJ, Ornstein DK, Prabhu VV,
Prange C, Schuler GD, Soares MB, Tolstoshev CM, Vocke CD,
Waterston RH: Molecular profiling of clinical tissue specimens.
J Mol Diagn 2000, 2(2):60-66.
2. Tureci O, Ding J, Hilton H, Bian H, Ohkawa H, Braxenthaler M, Seitz
G, Raddrizzani l, Friess H, Buchler M, Sahin U, Hammer J: Computa-
tional dissection of tissue contamination for identification of
colon cancer specific expression profiles.  FASEB J 2003,
17(3):376-385.
3. Benchekroun M, DeGraw J, Gao J, Sun L, Von Boguslawsky K, Lem-
inen A, Andersson LC, Heiskala M: Impact of fixative on recovery
of mRNA from paraffin-embedded tissue.  Diagn Mol Pathol
2004, 13(2):116-25.
4. Chung JY, Braunschweig T, Hewitt SM: Optimization of recovery
of RNA from formalin fixed, paraffin embedded tissue.  Diagn
Mol Pathol 2006, 15(4):229-236.
5. Abrahamsen HN, Steiniche T, Nexo E, Hamilton-Dutoit SJ, Sorensen
BS: Towards quantitative mRNA analysis in paraffin-embed-
ded tissues using real-time reverse transcriptase-polymer-
ase chain reaction.  J Mol Diagn 2003, 5(1):34-41.
6. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z,
Goldstein SR, Weiss RA, Liotta LA: Laser capture microdissec-
tion.  Science 1996, 274(5289):998-1001.
7. Srinivasan M, Sedmak D, Jewell S: Effects of fixatives and tissue
processing on the content and integrity of nucleic acids.  Am
J Pathol 2002, 161(6):1961-1971.
8. Mojica WD, Arshad A, Sharma S, Brooks SP: Manual exfoliation
plus immunomagnetic bead separation as an initial step
toward translational research.  Arch Pathol Lab Med 2006,
130(1):74-79.
9. Vincek F, Nassiri M, Knowles J, Nadji M, Morales AR: Preservation
of tissue RNA in normal saline.  Lab Invest 2003, 83(1):137-138.
10. Yang GC, Hoda SA: Combined use of the "Scratch and Smear"
sampling technique and ultrafast Papanicolaou stain for
intraoperative cytology.  Acta Cytol 1997, 41:1513-1518.
11. Mojica WD, Rapkiewicz AV, Liotta LA, Espina V: Manual exfolia-
tion of fresh tissue obviates the need for frozen sections for
molecular profiling.  Cancer Cytopathol 2005, 105(6):483-491.
12. Gaffey MJ, Mills SE, Swanson PB, Zarbo RJ, Shah AR, Wick MR:
Immunoreactivity for ber-Ep4 in adenocarcinomas, adeno-
matoid tumors, and malignant mesotheliomas.  Am J Surg
Pathol 1992, 16(6):593-599.
13. Sheibani K, Shin SS, Kezirian J, Weiss LM: Ber-Ep4 antibody as a
discriminant in the differential diagnosis of malignant mes-
othelioma versus adenocarcinoma.  Am J Surg Pathol 1991,
15(8):779-784.
14. Auer H, Lyianarachchi S, Newsom D, Klisovic MI, Marcucci G, Kor-
nacker K: Chipping away at the chip bias: RNA degradation in
microarray analysis.  Nat Genet 2003, 35:292-293.
15. Hawthorn L, Stein L, Panzarella J, Loewen GM, Baumann H: Charac-
terization of cell-type specific profiles in tissues and isolated
cells from squamous cell carcinomas of the lung.  Lung Cancer
2006, 53(2):129-142.
16. Copois V, Bret C, Bibeau F, Brouillet JP, del Rio M, Berthe ML,
Maudelonde T, Boulle N: Assessment of RNA quality extracted
from laser-captured tissues using miniaturized capillary
electrophoresis.  Lab Invest 2003, 83(4):599-602.
17. Huang J, Qi R, Quakenbush J, Dauway E, Lazaridis E, Yeatman T:
Effects of ischemia on gene expression.  J Surg Res 2001,
99(2):222-227.
18. Scicchitano MS, Dalmas DA, Beritiaux MA, Anderson SM, Turner LR,
Thomas RA, Mirable R, Boyce RW: Preliminary comparison of
quantity, quality, and microarray performance of RNA
extracted from formalin-fixed, paraffin-embedded, and
unfixed frozen tissue samples.  J Histo Cytochem 2006,
54(11):1229-1237.
19. Haller AC, Kanakapalli D, Walter R, Alhasan S, Eliason JF, Everson RB:
Transcriptional profiling of degraded RNA in cryopreserved
and fixed tissue samples obtained at autopsy.  BMC Clin Pathol
2006, 6:9.
20. Augenlicht LH, Velcich A, Klampfer L, Huang J, Corner G, Aranes M,
Laboisse C, Rigas B, Lipkin M, Yang K, Shi Q, Lesser M, Heerdt B,
Arango D, Yang WC, Wilson A, Mariadason JM: Application of
gene expression profiling to colon cell maturation, transfor-
mation and chemoprevention.  J Nutr 2003, 133:2410S-2416S.
21. Mariadason JM, Arango D, Corner GA, Aranes MJ, Hotchkiss KA,
Yang W, Augenlicht LH: A gene expression profile that defines
colon cell maturation in vitro.  Cancer Res 2002,
62(16):4791-4804.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6890/7/7/prepub